• Facebook - Portuguese Shoes
Portugueses Shoes TV

Dr. Martens’ main shareholder sells part of its shares


The Luxembourg company IngreLux, owned by funds advised by the private equity firm Permira, has announced that it has sold 65 million of its ordinary shares, at the price of 4.73 euros

This allowed the company to raise a total turnover of 257 million British pounds (307.7 million euros). According to shoeintelligence.com, the price represents a 6% discount from the previous day’s closing price, but is above the price set for Dr. Martens’ initial public offering in January 2021. Then, the iconic footwear brand had been valued at 4.2 billion euros.

IngreLux will hold, henceforth, a 36.4% stake in the British footwear company, which will not receive any proceeds from the placing. Barclays Bank and Goldman Sachs acted as joint bookrunners for the placing.

The market responded negatively to the news: Dr. Martens’ share price dropped almost 11%.


Image Credits: lechti.com
 
 
Breaking News
New qualifications for designers of sustainable footwear New qualifications for designers of sustainable footwear
Strong third quarter for Caleres Strong third quarter for Caleres
China: luxury online sales slowdown China: luxury online sales slowdown
Shoe Carnival announces third quarter results Shoe Carnival announces third quarter results
Gucci's Creative Director Alessandro Michele steps down Gucci's Creative Director Alessandro Michele steps down
Ecco Leather teams up with mycelium technology company Ecovative Ecco Leather teams up with mycelium technology company Ecovative
Ildemar Marchi de Almeida: sustainability is at the DNA of JBS Couros Ildemar Marchi de Almeida: sustainability is at the DNA of JBS Couros
AAFA applauds House for passing Inform Consumers Act AAFA applauds House for passing Inform Consumers Act
Tod's posts sales increase Tod's posts sales increase
Foot Locker raises guidance Foot Locker raises guidance
Terms and Conditions       Disclaimer